2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))

C126H91N18O10Pt5-3 — CID 159244589

IUPAC2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))
SMILESCN1C=CN(c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)o4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4nc(C)c(-c5ccccc5)o4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)o4)ccc3)ccc2)n1.Cc1nc(-c2[c-]c(Oc3[c-]c(-c4nccn4C)ccc3)ccc2)oc1-c1ccccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4cccnc4)o3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt]
InChIInChI=1S/C27H21N3O2.C26H19N3O2.C25H18N4O2.C24H17N4O2.C24H16N4O2.5Pt/c1-18-15-19(2)30(29-18)23-12-8-14-25(17-23)31-24-13-7-11-22(16-24)27-28-20(3)26(32-27)21-9-5-4-6-10-21;1-18-24(19-8-4-3-5-9-19)31-26(28-18)21-11-7-13-23(17-21)30-22-12-6-10-20(16-22)25-27-14-15-29(25)2;1-17-12-18(2)29(28-17)21-8-4-10-23(14-21)30-22-9-3-6-19(13-22)25-27-16-24(31-25)20-7-5-11-26-15-20;1-27-11-12-28(17-27)20-7-3-9-22(14-20)29-21-8-2-5-18(13-21)24-26-16-23(30-24)19-6-4-10-25-15-19;1-28-12-11-26-23(28)17-5-2-8-20(13-17)29-21-9-3-6-18(14-21)24-27-16-22(30-24)19-7-4-10-25-15-19;;;;;/h4-15H,1-3H3;3-15H,1-2H3;3-12,15-16H,1-2H3;2-12,15-17H,1H3;2-12,15-16H,1H3;;;;;/q3*-2;-3;-2;;4*+2
InChIKeyODFBIDZBECRCEO-UHFFFAOYSA-N
MW2992.62 g/mol
LogP28.54
Rot. Bonds25

About 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))

2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)) (PubChem CID 159244589) has the molecular formula C126H91N18O10Pt5-3 and a molecular weight of 2992.62 g/mol. Its IUPAC name is 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)).

Molecular Properties

Compound Name2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))
PubChem CID159244589
Molecular FormulaC126H91N18O10Pt5-3
Molecular Weight2992.62 g/mol
Exact Mass2990.54
IUPAC Name2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))
SMILESCN1C=CN(c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)o4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4nc(C)c(-c5ccccc5)o4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)o4)ccc3)ccc2)n1.Cc1nc(-c2[c-]c(Oc3[c-]c(-c4nccn4C)ccc3)ccc2)oc1-c1ccccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4cccnc4)o3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt]
InChIInChI=1S/C27H21N3O2.C26H19N3O2.C25H18N4O2.C24H17N4O2.C24H16N4O2.5Pt/c1-18-15-19(2)30(29-18)23-12-8-14-25(17-23)31-24-13-7-11-22(16-24)27-28-20(3)26(32-27)21-9-5-4-6-10-21;1-18-24(19-8-4-3-5-9-19)31-26(28-18)21-11-7-13-23(17-21)30-22-12-6-10-20(16-22)25-27-14-15-29(25)2;1-17-12-18(2)29(28-17)21-8-4-10-23(14-21)30-22-9-3-6-19(13-22)25-27-16-24(31-25)20-7-5-11-26-15-20;1-27-11-12-28(17-27)20-7-3-9-22(14-20)29-21-8-2-5-18(13-21)24-26-16-23(30-24)19-6-4-10-25-15-19;1-28-12-11-26-23(28)17-5-2-8-20(13-17)29-21-9-3-6-18(14-21)24-27-16-22(30-24)19-7-4-10-25-15-19;;;;;/h4-15H,1-3H3;3-15H,1-2H3;3-12,15-16H,1-2H3;2-12,15-17H,1H3;2-12,15-16H,1H3;;;;;/q3*-2;-3;-2;;4*+2
InChIKeyODFBIDZBECRCEO-UHFFFAOYSA-N
XLogP28.54
TPSA292.73 Ų
H-Bond Donors
H-Bond Acceptors28
Rotatable Bonds25
Heavy Atoms159
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002992.62
LogP ≤ 528.54
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1028

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))?
The IUPAC name of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)) (CID 159244589) is 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)).
What is the SMILES notation for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))?
The canonical SMILES for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)) is CN1C=CN(c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)o4)ccc3)ccc2)[CH-]1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4nc(C)c(-c5ccccc5)o4)ccc3)ccc2)n1.Cc1cc(C)n(-c2[c-]c(Oc3[c-]c(-c4ncc(-c5cccnc5)o4)ccc3)ccc2)n1.Cc1nc(-c2[c-]c(Oc3[c-]c(-c4nccn4C)ccc3)ccc2)oc1-c1ccccc1.Cn1ccnc1-c1[c-]c(Oc2[c-]c(-c3ncc(-c4cccnc4)o3)ccc2)ccc1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].[Pt].
What is the InChIKey of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))?
The InChIKey is ODFBIDZBECRCEO-UHFFFAOYSA-N. The full InChI is InChI=1S/C27H21N3O2.C26H19N3O2.C25H18N4O2.C24H17N4O2.C24H16N4O2.5Pt/c1-18-15-19(2)30(29-18)23-12-8-14-25(17-23)31-24-13-7-11-22(16-24)27-28-20(3)26(32-27)21-9-5-4-6-10-21;1-18-24(19-8-4-3-5-9-19)31-26(28-18)21-11-7-13-23(17-21)30-22-12-6-10-20(16-22)25-27-14-15-29(25)2;1-17-12-18(2)29(28-17)21-8-4-10-23(14-21)30-22-9-3-6-19(13-22)25-27-16-24(31-25)20-7-5-11-26-15-20;1-27-11-12-28(17-27)20-7-3-9-22(14-20)29-21-8-2-5-18(13-21)24-26-16-23(30-24)19-6-4-10-25-15-19;1-28-12-11-26-23(28)17-5-2-8-20(13-17)29-21-9-3-6-18(14-21)24-27-16-22(30-24)19-7-4-10-25-15-19;;;;;/h4-15H,1-3H3;3-15H,1-2H3;3-12,15-16H,1-2H3;2-12,15-17H,1H3;2-12,15-16H,1H3;;;;;/q3*-2;-3;-2;;4*+2.
What are the key properties of 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+))?
2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)) has a molecular weight of 2992.62 g/mol, XLogP of 28.54, 25 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-4-methyl-5-phenyl-1,3-oxazole;2-[3-[3-(3,5-dimethylpyrazol-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(3-methyl-2H-imidazol-2-id-1-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-pyridin-3-yl-1,3-oxazole;4-methyl-2-[3-[3-(1-methylimidazol-2-yl)benzene-2-id-1-yl]oxybenzene-2-id-1-yl]-5-phenyl-1,3-oxazole;platinum;tetrakis(platinum(2+)) is sourced from PubChem (CID 159244589), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).